-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 MdM87aHjVeOqPdYpw6IkkOXoz1V96JjustWsg4T90HPCV6GFn267acQkfLxcEG05
 01bbPPO21VXzqfWHMqNENQ==

<SEC-DOCUMENT>0000912057-96-011432.txt : 19960605
<SEC-HEADER>0000912057-96-011432.hdr.sgml : 19960605
ACCESSION NUMBER:		0000912057-96-011432
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		19960604
SROS:			NASD

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CORTEX PHARMACEUTICALS INC/DE/
		CENTRAL INDEX KEY:			0000849636
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				330303583
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	033-71894
		FILM NUMBER:		96576345

	BUSINESS ADDRESS:	
		STREET 1:		15241 BARRANCA PKWY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92718
		BUSINESS PHONE:		7147273157

	MAIL ADDRESS:	
		STREET 2:		15241 BARRANCA PARKWAY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92718
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<DESCRIPTION>PROSPECTUS SUPPLEMENT
<TEXT>

<PAGE>
                       SUPPLEMENT NO. 1 DATED JUNE 4, 1996

                            SUPPLEMENT TO PROSPECTUS
                             DATED JANUARY 30, 1996 
                                       OF
                          CORTEX PHARMACEUTICALS, INC.


APPOINTMENT OF PRESIDENT AND CHIEF EXECUTIVE OFFICER

     On May 15, 1996, Vincent F. Simmon, Ph.D., was appointed President, Chief
Executive Officer and a member of the Board of Directors of Cortex
Pharmaceuticals, Inc., effective immediately.  
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----